Monopar Therapeutics
MNPR
MNPR
18 hedge funds and large institutions have $57.1M invested in Monopar Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$23.4M | |
| 2 | +$13.2M | |
| 3 | +$11.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.69M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.86M |